🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eduardo Aliprandini

AstraZeneca (United Kingdom)

ORCID: 0000-0003-3651-775X

Also affiliated with Inserm, Institut Pasteur, Université Paris Cité, AstraZeneca (Brazil), Institute of Infection and Immunity

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies”.

Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.901253

N/A

0.373DataRank · unranked

11 citations

Gaily Kivi, Raini Pert, Erkki Juronen, Pavlo Holenya, Eduardo Aliprandini +12 more

The Anopheles leucine-rich repeat protein APL1C is a pathogen binding factor recognizing Plasmodium ookinetes and sporozoites

PLoS Pathogens(2024)10.1371/journal.ppat.1012008

N/A

0.373DataRank · unranked

11 citations

Catherine Lavazec, Emma Brito‐Fravallo, Corinne Genève, Eduardo Aliprandini, Manuela C. Aguirre-Botero +3 more

Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection

Cell Reports(2023)10.1016/j.celrep.2023.112681

N/A

0DataRank · unranked

21 citations

Lawrence Wang, Pauline Formaglio, Eduardo Aliprandini, Jean-Michel Thiberge, Arne Schön +14 more